Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.48 and traded as low as $0.48. Elite Pharmaceuticals shares last traded at $0.48, with a volume of 438,479 shares traded.
Elite Pharmaceuticals Stock Down 1.4 %
The firm has a market cap of $505.87 million, a P/E ratio of -23.68 and a beta of 0.14. The company has a quick ratio of 1.90, a current ratio of 3.27 and a debt-to-equity ratio of 0.12. The firm has a fifty day moving average of $0.50 and a 200-day moving average of $0.49.
Elite Pharmaceuticals (OTCMKTS:ELTP – Get Free Report) last released its earnings results on Thursday, February 13th. The specialty pharmaceutical company reported ($0.01) earnings per share (EPS) for the quarter. Elite Pharmaceuticals had a negative return on equity of 6.92% and a negative net margin of 25.70%.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
See Also
- Five stocks we like better than Elite Pharmaceuticals
- What is Insider Trading? What You Can Learn from Insider Trading
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- 3 Monster Growth Stocks to Buy Now
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- EV Stocks and How to Profit from Them
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
